BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31662537)

  • 1. Influence of Mixed Chimerism on Outcome in Children With Anaemia After Haematopoietic Stem Cell Transplantation.
    Lejman M; Zawitkowska J; Zaucha-Prażmo A; Cienkusz M; Mroczkowska A; Kowalczyk J; Drabko K
    In Vivo; 2019; 33(6):2051-2057. PubMed ID: 31662537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of early chimerism status on clinical outcome in children with acute lymphoblastic leukaemia after haematopoietic stem cell transplantation.
    Lejman M; Zaucha-Prażmo A; Zawitkowska J; Mroczkowska A; Grabowski D; Kowalczyk JR; Drabko K
    BMC Cancer; 2019 Nov; 19(1):1141. PubMed ID: 31771553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
    Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
    Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].
    Zhou J; Fu YW; Liang LJ; Wang Q; Han LJ; Zu YL; Zhang Y; Zhu XH; Yu FK; Fang BJ; Wei XD; Song YP
    Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):927-931. PubMed ID: 27916046
    [No Abstract]   [Full Text] [Related]  

  • 5. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T Cells.
    Grimaldi F; Potter V; Perez-Abellan P; Veluchamy JP; Atif M; Grain R; Sen M; Best S; Lea N; Rice C; Pagliuca A; Mufti GJ; Marsh JCW; Barber LD
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):293-299. PubMed ID: 27816648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease.
    Choi YB; Lee JW; Sung KW; Koo HH; Kim HJ; Yoo KH
    J Korean Med Sci; 2019 Feb; 34(6):e46. PubMed ID: 30787679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Chimerism Dynamics after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Nonmalignant Diseases.
    Faraci M; Bagnasco F; Leoni M; Giardino S; Terranova P; Subissi L; Di Duca M; Di Martino D; Lanino E
    Biol Blood Marrow Transplant; 2018 May; 24(5):1088-1093. PubMed ID: 29292059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].
    Ai HS; Yu CL; Wang DH; Guo M; Qiao JH; Shi BF; Sun WJ; Zhang S; Sun QY; Yao B
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):208-11. PubMed ID: 12812663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of Chinese medicine with allogeneic hematopoietic stem cell transplantation for severe aplastic anemia patients.
    Ye BD; Zhang X; Shao KD; Chen D; Zhang Y; Wu DJ; Yu QH; Shen JP; Shen YP; Zhou YH
    Chin J Integr Med; 2014 Dec; 20(12):903-9. PubMed ID: 25428338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group.
    Chen J; Lee V; Luo CJ; Chiang AK; Hongeng S; Tan PL; Tan AM; Sanpakit K; Li CF; Lee AC; Chua HC; Okamoto Y
    Br J Haematol; 2013 Aug; 162(3):383-91. PubMed ID: 23735201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen.
    Saito B; Fukuda T; Yokoyama H; Kurosawa S; Takahashi T; Fuji S; Takahashi N; Tajima K; Kim SW; Mori SI; Tanosaki R; Takaue Y; Heike Y
    Biol Blood Marrow Transplant; 2008 Oct; 14(10):1148-1155. PubMed ID: 18804045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimerism patterns of long-term stable mixed chimeras posthematopoietic stem cell transplantation in patients with nonmalignant diseases: follow-up of long-term stable mixed chimerism patients.
    Stikvoort A; Gertow J; Sundin M; Remberger M; Mattsson J; Uhlin M
    Biol Blood Marrow Transplant; 2013 May; 19(5):838-44. PubMed ID: 23462188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease.
    Strocchio L; Zecca M; Comoli P; Mina T; Giorgiani G; Giraldi E; Vinti L; Merli P; Regazzi M; Locatelli F
    Br J Haematol; 2015 Jun; 169(5):726-36. PubMed ID: 25818248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation].
    Niedzielska E; Wójcik D; Barg E; Pietras W; Sega-Pondel D; Doroszko A; Niedzielska M; Skarzyńska M; Chybicka A
    Med Wieku Rozwoj; 2008; 12(3):761-6. PubMed ID: 19305027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimerism in pediatric hematopoietic stem cell transplantation and its correlation with the clinical outcome.
    Gabr H; Youssry I; El-Ansary Y; Mosallam G; Riad NM; Hanna MOF
    Transpl Immunol; 2017 Dec; 45():53-58. PubMed ID: 28951259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-Transplant CD34
    Chandra S; Bleesing JJ; Jordan MB; Grimley MS; Khandelwal P; Davies SM; Edwards S; Leemhuis T; Marsh RA
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1527-1529. PubMed ID: 29555312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia.
    McCann S; Passweg J; Bacigalupo A; Locasciulli A; Locatelli F; Ryan J; Schrezenmeier H; Lawler M
    Bone Marrow Transplant; 2007 Jan; 39(2):109-14. PubMed ID: 17173053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation With Unrelated Cord Blood Unit in Patients Aged 35 to 50 Years With Severe Aplastic Anemia: Preliminary Summary of a Single-Arm Trial.
    Yang Y; Xu H; He H; Qi J; Yan J; Wang N; Huang D
    Transplant Proc; 2019 Dec; 51(10):3431-3436. PubMed ID: 31733793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fludarabine-based increased-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia].
    Sun C; Lin X; Huang Y; Song C; Tao Y; Tu S; Fang J; Chen T; Sun C; Wu B
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):221-4. PubMed ID: 24666488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.